Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Tmem178a | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of TMEM178 mRNA | CTD | PMID:25380136 | Tmem178a | Rat | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of TMEM178A mRNA | CTD | PMID:32145629 | Tmem178a | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TMEM178 mRNA; Tetrachlorodibenzodioxin results in decreased expression of TMEM178A more ... | CTD | PMID:20106945|PMID:21632981 | Tmem178a | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TMEM178A mRNA | CTD | PMID:32109520|PMID:33387578 | Tmem178a | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of TMEM178 mRNA | CTD | PMID:22298810 | Tmem178a | Rat | 4,4'-sulfonyldiphenol | decreases methylation | ISO | TMEM178A (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of TMEM178A gene | CTD | PMID:31601247 | Tmem178a | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of TMEM178A mRNA | CTD | PMID:31881176 | Tmem178a | Rat | aflatoxin B1 | affects expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of TMEM178A protein | CTD | PMID:20106945 | Tmem178a | Rat | aflatoxin B1 | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of TMEM178A mRNA | CTD | PMID:32234424 | Tmem178a | Rat | aflatoxin B1 | decreases methylation | ISO | TMEM178A (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of TMEM178A intron | CTD | PMID:30157460 | Tmem178a | Rat | Aflatoxin B2 alpha | decreases methylation | ISO | TMEM178A (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of TMEM178A intron | CTD | PMID:30157460 | Tmem178a | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TMEM178A mRNA | CTD | PMID:35163327 | Tmem178a | Rat | arsenous acid | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of TMEM178A mRNA | CTD | PMID:26705709 | Tmem178a | Rat | benzo[a]pyrene | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of TMEM178 mRNA; Benzo(a)pyrene results in decreased expression of TMEM178A more ... | CTD | PMID:20106945|PMID:21632981|PMID:32234424 | Tmem178a | Rat | benzo[a]pyrene | increases methylation | ISO | TMEM178A (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of TMEM178 exon; Benzo(a)pyrene results in increased methylation of TMEM178 more ... | CTD | PMID:27901495 | Tmem178a | Rat | benzo[b]fluoranthene | increases expression | ISO | Tmem178 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of TMEM178 mRNA | CTD | PMID:26377693 | Tmem178a | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of TMEM178 mRNA | CTD | PMID:25181051 | Tmem178a | Rat | bisphenol A | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of TMEM178A gene | CTD | PMID:31601247 | Tmem178a | Rat | bisphenol A | decreases expression | ISO | Tmem178 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of TMEM178 mRNA | CTD | PMID:32365465|PMID:34585602|PMID:39742910 | Tmem178a | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TMEM178A mRNA | CTD | PMID:32145629 | Tmem178a | Rat | carbon nanotube | decreases expression | ISO | Tmem178 (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of TMEM178 mRNA | CTD | PMID:25554681 | Tmem178a | Rat | chloroprene | decreases expression | ISO | Tmem178 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of TMEM178 mRNA | CTD | PMID:23125180 | Tmem178a | Rat | choline | multiple interactions | ISO | Tmem178 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Tmem178a | Rat | cyclosporin A | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of TMEM178 mRNA; Cyclosporine results in decreased expression of TMEM178A more ... | CTD | PMID:20106945|PMID:25562108 | Tmem178a | Rat | diarsenic trioxide | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of TMEM178A mRNA | CTD | PMID:26705709 | Tmem178a | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of TMEM178 mRNA | CTD | PMID:21266533 | Tmem178a | Rat | dioxygen | multiple interactions | ISO | Tmem178 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM178 mRNA | CTD | PMID:30529165 | Tmem178a | Rat | dorsomorphin | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Tmem178a | Rat | entinostat | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | entinostat results in decreased expression of TMEM178A mRNA | CTD | PMID:26272509 | Tmem178a | Rat | entinostat | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Tmem178a | Rat | fenamidone | decreases expression | ISO | Tmem178 (Mus musculus) | 6480464 | fenamidone results in decreased expression of TMEM178 mRNA | CTD | PMID:27029645 | Tmem178a | Rat | folic acid | multiple interactions | ISO | Tmem178 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Tmem178a | Rat | fulvestrant | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of TMEM178A gene | CTD | PMID:31601247 | Tmem178a | Rat | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of TMEM178 gene | CTD | PMID:22079235 | Tmem178a | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of TMEM178A mRNA | CTD | PMID:27387713 | Tmem178a | Rat | genistein | increases expression | ISO | Tmem178 (Mus musculus) | 6480464 | Genistein results in increased expression of TMEM178 mRNA | CTD | PMID:32186404 | Tmem178a | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of TMEM178A mRNA | CTD | PMID:33387578 | Tmem178a | Rat | inulin | multiple interactions | ISO | Tmem178 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM178 mRNA | CTD | PMID:36331819 | Tmem178a | Rat | L-methionine | multiple interactions | ISO | Tmem178 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Tmem178a | Rat | lipopolysaccharide | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TMEM178A mRNA | CTD | PMID:35811015 | Tmem178a | Rat | manganese(II) chloride | decreases expression | EXP | | 6480464 | manganese chloride results in decreased expression of TMEM178A mRNA | CTD | PMID:28801915 | Tmem178a | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of TMEM178A gene | CTD | PMID:35440735 | Tmem178a | Rat | methylmercury chloride | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of TMEM178A mRNA | CTD | PMID:28001369 | Tmem178a | Rat | N-methyl-4-phenylpyridinium | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of TMEM178A mRNA | CTD | PMID:24810058 | Tmem178a | Rat | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of TMEM178 mRNA | CTD | PMID:25380136 | Tmem178a | Rat | N-Nitrosopyrrolidine | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of TMEM178A mRNA | CTD | PMID:32234424 | Tmem178a | Rat | nickel atom | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Nickel results in decreased expression of TMEM178A mRNA | CTD | PMID:24768652|PMID:25583101 | Tmem178a | Rat | O-methyleugenol | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of TMEM178A mRNA | CTD | PMID:32234424 | Tmem178a | Rat | okadaic acid | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of TMEM178A mRNA | CTD | PMID:38832940 | Tmem178a | Rat | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of TMEM178 mRNA; oxaliplatin results in increased expression of TMEM178A more ... | CTD | PMID:25729387 | Tmem178a | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] affects the expression of TMEM178 mRNA; [Topotecan co-treated with oxaliplatin] results more ... | CTD | PMID:25729387 | Tmem178a | Rat | ozone | multiple interactions | ISO | Tmem178 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TMEM178 more ... | CTD | PMID:34911549 | Tmem178a | Rat | p-chloromercuribenzoic acid | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of TMEM178A mRNA | CTD | PMID:26272509 | Tmem178a | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Tmem178a | Rat | panobinostat | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Tmem178a | Rat | panobinostat | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | panobinostat results in decreased expression of TMEM178A mRNA | CTD | PMID:26272509 | Tmem178a | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of TMEM178A mRNA | CTD | PMID:33387578 | Tmem178a | Rat | pentane-2,3-dione | increases expression | EXP | | 6480464 | 2,3-pentanedione results in increased expression of TMEM178 mRNA | CTD | PMID:25710175 | Tmem178a | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Tmem178 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM178 mRNA | CTD | PMID:36331819 | Tmem178a | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TMEM178A mRNA | CTD | PMID:35163327 | Tmem178a | Rat | quercetin | affects expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Quercetin affects the expression of TMEM178 mRNA | CTD | PMID:21632981 | Tmem178a | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TMEM178A mRNA | CTD | PMID:35811015 | Tmem178a | Rat | SB 431542 | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Tmem178a | Rat | silicon dioxide | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of TMEM178 mRNA | CTD | PMID:25895662 | Tmem178a | Rat | sodium arsenite | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of TMEM178A mRNA | CTD | PMID:29301061 | Tmem178a | Rat | sunitinib | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of TMEM178A mRNA | CTD | PMID:31533062 | Tmem178a | Rat | titanium dioxide | affects expression | ISO | Tmem178 (Mus musculus) | 6480464 | titanium dioxide affects the expression of TMEM178 mRNA | CTD | PMID:23557971 | Tmem178a | Rat | titanium dioxide | increases methylation | ISO | Tmem178 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of TMEM178 gene | CTD | PMID:35295148 | Tmem178a | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] affects the expression of TMEM178 mRNA; [Topotecan co-treated with oxaliplatin] results more ... | CTD | PMID:25729387 | Tmem178a | Rat | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of TMEM178 mRNA; Topotecan results in increased expression of TMEM178A more ... | CTD | PMID:25729387 | Tmem178a | Rat | trichostatin A | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of TMEM178 mRNA; trichostatin A results in decreased expression more ... | CTD | PMID:24935251|PMID:26272509 | Tmem178a | Rat | trichostatin A | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Tmem178a | Rat | valproic acid | decreases methylation | ISO | TMEM178A (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of TMEM178A gene | CTD | PMID:29154799 | Tmem178a | Rat | valproic acid | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Tmem178a | Rat | valproic acid | affects expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TMEM178A mRNA | CTD | PMID:25979313 | Tmem178a | Rat | valproic acid | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of TMEM178 mRNA; Valproic Acid results in decreased expression more ... | CTD | PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386 | Tmem178a | Rat | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of TMEM178 mRNA | CTD | PMID:20566332 | Tmem178a | Rat | vorinostat | multiple interactions | ISO | TMEM178A (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Tmem178a | Rat | vorinostat | decreases expression | ISO | TMEM178A (Homo sapiens) | 6480464 | vorinostat results in decreased expression of TMEM178A mRNA | CTD | PMID:26272509|PMID:27188386 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















